Further corroborating this, a study by Gao et al. confirmed that CCNG2 can inhibit the growth and metastasis of gastric cancer both in vitro and in vivo, an effect closely related to its suppression of the Wnt/β-catenin signaling pathway (Gao et al., 2018). Here, CCNG2 is linked to gastric cancer.